Ergocalciferol (Vitamin D2).

Ergocalciferol is hydroxylated to an active metabolite that raises intestinal calcium transporter expression, so the calcium it acts on has to be present in the diet.

Both the 25-hydroxylase and the 1-alpha-hydroxylase that activate ergocalciferol are magnesium-dependent, as is the vitamin D binding protein that carries the metabolites. Low magnesium slows activation of any vitamin D form.

Vitamin D signalling raises synthesis of osteocalcin and matrix Gla protein, and vitamin K adds the carboxyl groups those proteins need to bind calcium.

D2 and D3 feed the same receptor but 25-OH-D2 binds the carrier protein more weakly and clears faster, so equal doses do not hold 25-OH-D equally. Taken together they should be counted as one vitamin D intake, and D2 can lower the measured 25-OH-D3 fraction.

The vitamin D receptor must pair with the retinoid X receptor to bind DNA, so retinoid supply shapes the response and a large preformed retinol load can compete for that partner.

The vitamin D receptor holds DNA through zinc-finger motifs, so zinc is structural to the receptor that ergocalciferol's metabolite acts on.

Ergocalciferol is absorbed in mixed micelles, so taking it with long-chain fat raises the absorbed fraction over an empty stomach.

Fat-soluble vitamins share micelle space and intestinal transporters, so a large tocopherol dose alongside can modestly lower uptake.

Boron intake tracks with higher circulating 25-hydroxyvitamin D, apparently by slowing catabolic clearance of the metabolite rather than adding vitamin D. The link is an association.

Ergocalciferol dissolves in fat, not water. Taking it with a fat source such as MCT oil or a fat containing meal supports micelle formation and passive uptake in the small intestine. Fasted dosing with water gives the molecule no vehicle. This is absorption chemistry, not an effect on any body outcome.

Lecithin is a phospholipid emulsifier used to disperse fat soluble vitamins in powders, emulsions and softgels. It lowers interfacial tension so a lipophilic vitamin stays dispersed rather than separating out. The relevance here is delivery and physical stability of the dose, not a change in what ergocalciferol does once absorbed.

Bile mixed micelles that carry fat soluble vitamins are built from bile salts and phospholipid, phosphatidylcholine chief among them. A phosphatidylcholine rich vehicle mimics that arrangement in the dosage form. The step it supports is solubilisation before uptake.

Any long chain triglyceride oil can carry ergocalciferol into the micellar phase, and flaxseed oil is one such carrier used in liquid drops. Its polyunsaturated fatty acids oxidise readily, so formulations pair it with an antioxidant and protective packaging. The interaction is delivery and stability rather than a physiological partnership.

Without bile acids reaching the duodenum, fat soluble vitamin uptake drops sharply. That dependence is textbook. Whether supplemental ox bile restores uptake of ergocalciferol in people with low bile output has thinner grounding, so the row sits at Promising and belongs with clinician oversight rather than casual stacking.

Pancreatic lipase must free fatty acids from dietary triglyceride before mixed micelles form and carry a fat soluble vitamin across the brush border. Enzyme preparations that include lipase support that upstream step when native output is low. The mechanism is well described; the specific gain for ergocalciferol has not been quantified here.

A viscous soluble fibre gel slows mixing of the lipid phase with bile and thickens intestinal contents, which can lower uptake of a fat soluble vitamin taken at the same time. Nothing is lost if the two are spaced apart. The interaction is about timing rather than incompatibility.

Activated charcoal adsorbs lipophilic organic molecules indiscriminately, so a dose taken alongside ergocalciferol can bind it in the gut lumen before uptake. This is a physical binding effect, not an effect on vitamin D metabolism. Charcoal is dosed well away from any nutrient it could carry out with it.

1,25 dihydroxyvitamin D drives transcription of the intestinal calcium transport machinery, so vitamin D status sets how efficiently a calcium dose is absorbed. Calcium carbonate is the acid dependent salt, which is why it is taken with food rather than fasted. Together they cover supply and absorption efficiency of the same mineral.

Vitamin D signalling increases osteocalcin expression, and osteocalcin only becomes functional after vitamin K dependent gamma carboxylation. Vitamin K1 is the dietary phylloquinone form, cleared quickly and taken up mainly by the liver. The shared pathway is well described; head to head evidence for the K1 form alongside vitamin D2 specifically is thin.

Strontium follows much of the same intestinal and skeletal handling as calcium, and that handling is vitamin D responsive. Raising vitamin D status therefore changes strontium uptake as well, and strontium competes with calcium for the same route. Anyone combining them is altering two mineral balances at once, which is a reason for measurement rather than assumption.